New VEGF antagonists as possible therapeutic agents in vascular disease

Slevin, Mark, Kumar, Patricia, Wang, Qiuyu, Kumar, Shant, Gaffney, John, Grau-Olivares, Marta and Krupinski, Jerzy (2008) New VEGF antagonists as possible therapeutic agents in vascular disease. Expert opinion on investigational drugs, 17 (9). pp. 1301-1314. ISSN 1354-3784

File not available for download.

Abstract

BACKGROUND: In this review we provide the reader with an analysis of the importance of VEGF in modulating the angiogenic process in vascular diseases. OBJECTIVES: We have described the key role of VEGF in the development of the major angiogenic diseases including ocular retinopathies, solid tumour growth and atherosclerotic plaque development. METHODS: Following a brief description of the disease, a detailed literature review of the mechanisms through which VEGF induces promotion of neovascularisation and current anti-VEGF therapies is provided for the reader. RESULTS/CONCLUSIONS: Current and future potential clinical therapies are discussed in particular concerning our thoughts on future directives involving adenoviral-mediated gene targeting, nanotechnology and combinational therapies.